SCHEMBL29348778

SCHEMBL29348778

Cc1ccc(N2CCCN(C)C2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.53
DRD3 P35462 2/20 0.53
F2 P00734 1/20 0.45
ELANE P08246 1/20 0.45
CTSG P08311 1/20 0.45
CMA1 P23946 1/20 0.45
CTRC Q99895 1/20 0.45
GAA P10253 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALOX5 P09917 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15448368 0.89 DRD2 (0.55) DRD2DRD3F2ELANECTSG
SCHEMBL4711615 0.85 MAPT (0.44) DRD2DRD3F2GAAHTT
SCHEMBL29348779 0.84 MEN1 (0.38) DRD2DRD3F2RAB9ANPC1
SCHEMBL6362778 0.83 MEN1 (0.61) DRD2DRD3RAB9ANPC1MEN1
SCHEMBL25685276 0.81 MGLL (0.43) DRD2DRD3SMN1; SMN2RAB9ANPC1
SCHEMBL20057689 0.81 DRD2 (0.36) DRD2DRD3GAASMN1; SMN2RAB9A
SCHEMBL20313983 0.81 GAA (0.49) DRD2DRD3GAAHTTRAB9A
SCHEMBL14337562 0.80 DRD2 (0.48) DRD2DRD3F2ELANECTSG
SCHEMBL2555563 0.80 HRH3 (0.37) DRD2DRD3F2RAB9ANPC1
SCHEMBL21594891 0.80 CHKA (0.50) DRD2DRD3F2SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed